88 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
20 May 24
ENDRA Provides Update Following In-person Meeting with FDA
8:05am
strategy; and statements regarding ENDRA’s ability to find and maintain development partners. Forward-looking statements involve inherent risks
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
14 May 24
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
4:17pm
concerning ENDRA's business strategy; and statements regarding ENDRA’s ability to find and maintain development partners. Forward-looking statements
424B5
NDRA
ENDRA Life Sciences Inc
3 Apr 24
Prospectus supplement for primary offering
5:15pm
and revenue; expectations concerning our business strategy; and statements regarding our ability to find and maintain development partners.
Forward-looking … reliance on third parties, collaborations, strategic alliances and licensing arrangements to complete our business strategy;
the amount and nature
424B5
7qtblpf
3 Apr 24
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
pp9m3nxyo atyznp
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
w7zrovsj1fh49klx9vp4
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.2
4tn4g2mi 6usib9
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
znhb tp65djwtvl2
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
433siawokt4n
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
EX-99.1
nf7lf
6 Jul 23
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
53v1 nepz7
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am